These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7685864)

  • 41. Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry.
    Callaghan PD; Irvine RJ; Daws LC
    Neurochem Int; 2005 Oct; 47(5):350-61. PubMed ID: 15979209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylenedioxymethamphetamine induces spontaneous tail-flicks in the rat via 5-HT1A receptors.
    Millan MJ; Colpaert FC
    Eur J Pharmacol; 1991 Feb; 193(2):145-52. PubMed ID: 1675609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices.
    Fitzgerald JL; Reid JJ
    Eur J Pharmacol; 1990 Nov; 191(2):217-20. PubMed ID: 1982265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity.
    Brodkin J; Malyala A; Nash JF
    Pharmacol Biochem Behav; 1993 Jul; 45(3):647-53. PubMed ID: 8101380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.
    O'Loinsigh ED; Boland G; Kelly JP; O'Boyle KM
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):621-38. PubMed ID: 11371001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites.
    Battaglia G; Brooks BP; Kulsakdinun C; De Souza EB
    Eur J Pharmacol; 1988 Apr; 149(1-2):159-63. PubMed ID: 2899513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
    Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
    Ann N Y Acad Sci; 2004 Oct; 1025():189-97. PubMed ID: 15542717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
    Insel TR; Battaglia G; Johannessen JN; Marra S; De Souza EB
    J Pharmacol Exp Ther; 1989 Jun; 249(3):713-20. PubMed ID: 2471824
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA.
    Gollamudi R; Ali SF; Lipe G; Newport G; Webb P; Lopez M; Leakey JE; Kolta M; Slikker W
    Neurotoxicology; 1989; 10(3):455-66. PubMed ID: 2576302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA).
    Lowy MT; Nash JF; Meltzer HY
    Eur J Pharmacol; 1989 Apr; 163(1):157-61. PubMed ID: 2472965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys.
    Kleven MS; Woolverton WL; Seiden LS
    Brain Res; 1989 May; 488(1-2):121-5. PubMed ID: 2472850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI; Green AR
    Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
    Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N
    Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices.
    Johnson MP; Hoffman AJ; Nichols DE
    Eur J Pharmacol; 1986 Dec; 132(2-3):269-76. PubMed ID: 2880735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan.
    Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK
    Eur J Pharmacol; 1990 Mar; 178(3):313-20. PubMed ID: 1971220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. No modulatory effect of neurokinin-1 receptor antagonists on serotonin uptake in human and rat brain synaptosomes.
    Lieb K; Fiebich BL; Herpfer I; Mantovani M; Löffler M; Feuerstein TJ
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):641-6. PubMed ID: 15990280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.
    O'Hearn E; Battaglia G; De Souza EB; Kuhar MJ; Molliver ME
    J Neurosci; 1988 Aug; 8(8):2788-803. PubMed ID: 2457659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MDMA: further evidence that its action in the medial prefrontal cortex is mediated by the serotonergic system.
    Pan HS; Wang RY
    Brain Res; 1991 Jan; 539(2):332-6. PubMed ID: 1675911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats.
    Lizarraga LE; Phan AV; Cholanians AB; Herndon JM; Lau SS; Monks TJ
    Toxicol Sci; 2014 Jun; 139(2):421-31. PubMed ID: 24595820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR.
    Colado MI; Granados R; O'Shea E; Esteban B; Green AR
    Br J Pharmacol; 1998 Jun; 124(3):479-84. PubMed ID: 9647471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.